Vision functions other than standard visual acuity may affect day-to-day functioning of older adults. Additional studies of these other aspects of vision and how they can be treated or rehabilitated are needed to determine whether these aspects play a role in strategies for reducing disability in older adults.
We present an overview of a multifaceted longitudinal study of vision function and its interaction with daily activities, health, and well-being among 900 persons aged 58 to 102 years at the first visit. Standard vision measures as well as nonconventional tests designed to assess visual performance under the nonideal conditions encountered in everyday life were used. Here we summarize a few of the findings to date, with an emphasis on a direct comparison of declines in different aspects of vision function with age. The rates of declines with advancing age vary widely for the different vision functions. Also described is the reading performance of the sample and its association with some of the vision measures. Furthermore, we describe some of the associations between vision test scores and extensive longitudinal health and functioning data collected by the Buck Center for Research in Aging. Findings show that many older people with good acuity are effectively visually impaired in performing everyday tasks involving low and changing light levels, stereopsis, glare, and low contrast. We also found that vision under nonideal conditions cannot be predicted from standard acuity on an individual basis.
Including both cessation and self-restriction, men over age 85 years are 6.6 times more likely than women to be driving at night. For both genders, vision plays a significant role in the self-restriction decision. A higher percentage of men than women continue to drive at night with poor vision. Men's night-driving cessation was associated with contrast sensitivity and depression, whereas women's night-driving cessation was associated with low-contrast acuity in glare as well as age.
The marked decline in face recognition ability in elders is related to declines in spatial vision and cognitive status. All spatial vision measures have similar predictive ability for face recognition.
Other spatial vision measures cannot be predicted on an individual basis from visual acuity despite high and significant correlations between the measures.
Older adults with early changes in spatial vision function and depth perception appear to recognize their limitations and restrict their driving even if they do not acknowledge the visual impairment as the cause for restriction. Poor visual attention, a risk factor for crashes, may not be recognized. Additional studies of driving self-restriction in relation to risk factors for crashes in older adults may help refine this strategy of reducing driving-related injury and death.
This article provides an overview of some of the problems and possible solutions surrounding the neglected issue of combined vision and hearing deficits. The subject is treated by considering each subpopulation, ranging from those who have no residual vision or hearing to those with mild coexisting vision and hearing losses. An attempt is made to relate the different types of visual deficit to the likely problems encountered in real-life activities, such as communication and travel, among individuals who also have a hearing impairment. The assessment and appropriate referral of patients with these combined deficits is discussed, including the interpretation of visual test results and the importance of factors other than standard visual acuity. Speculation is offered on potential strategies and solutions for rehabilitation as well as the need for future research and improvements in service delivery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.